TNF alpha inhibitor (Ganial Immunotherapeutics/Institute for Biological Research)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTNF alpha inhibitor (Ganial Immunotherapeutics/Institute for Biological Research)
Drug Alias NameGIT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 beta inhibitorsMacrophage migration inhibitory factor inhibitorsNitric oxide synthase, inducible inhibitors +[4] 
TargetsMacrophage migration inhibitory factorTumor necrosis factor αInterleukin-1 beta +[4] 
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGanial Immunotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGanial Immunotherapeutics
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A